Cresco Labs Future Growth
Future criteria checks 3/6
Cresco Labs is forecast to grow earnings and revenue by 97.2% and 5.1% per annum respectively while EPS is expected to grow by 98.1% per annum.
Key information
97.2%
Earnings growth rate
98.1%
EPS growth rate
Pharmaceuticals earnings growth | 56.9% |
Revenue growth rate | 5.1% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 07 Apr 2024 |
Recent future growth updates
Recent updates
Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41
Mar 16Investors Don't See Light At End Of Cresco Labs Inc.'s (CSE:CL) Tunnel And Push Stock Down 32%
Mar 03Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt
Jan 26Risks To Shareholder Returns Are Elevated At These Prices For Cresco Labs Inc. (CSE:CL)
Jan 04Is Cresco Labs (CSE:CL) Using Too Much Debt?
Sep 22Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 33%
Aug 11Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet
Jan 25Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 24%?
Dec 13We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt
Aug 22Estimating The Intrinsic Value Of Cresco Labs Inc. (CSE:CL)
May 23Cresco Labs Inc. (CSE:CL) Analysts Are Way More Bearish Than They Used To Be
Mar 24Estimating The Fair Value Of Cresco Labs Inc. (CSE:CL)
Feb 02Cresco Labs Inc. (CSE:CL) Shares Could Be 41% Below Their Intrinsic Value Estimate
Oct 27Cresco Labs (CSE:CL) Takes On Some Risk With Its Use Of Debt
Oct 06Cresco Labs Inc. (CSE:CL) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates
Mar 27Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 868 | 97 | -2 | 26 | 2 |
12/31/2025 | 793 | -39 | 36 | 51 | 9 |
12/31/2024 | 744 | -30 | 30 | 69 | 13 |
12/31/2023 | 756 | -176 | 1 | 59 | N/A |
9/30/2023 | 767 | -339 | -1 | 65 | N/A |
6/30/2023 | 786 | -234 | -23 | 50 | N/A |
3/31/2023 | 806 | -211 | -44 | 25 | N/A |
12/31/2022 | 825 | -212 | -67 | 19 | N/A |
9/30/2022 | 842 | -65 | -38 | 53 | N/A |
6/30/2022 | 848 | -326 | -62 | 34 | N/A |
3/31/2022 | 841 | -318 | -114 | -2 | N/A |
12/31/2021 | 806 | -320 | -83 | 14 | N/A |
9/30/2021 | 750 | -360 | -99 | -3 | N/A |
6/30/2021 | 687 | -73 | -74 | 20 | N/A |
3/31/2021 | 573 | -105 | -25 | 43 | N/A |
12/31/2020 | 463 | -102 | -97 | -8 | N/A |
9/30/2020 | 345 | -76 | -149 | -34 | N/A |
6/30/2020 | 231 | -98 | -186 | -70 | N/A |
3/31/2020 | 168 | -64 | -185 | -57 | N/A |
12/31/2019 | 124 | -43 | -121 | -25 | N/A |
9/30/2019 | 101 | -20 | -94 | -29 | N/A |
6/30/2019 | 78 | -14 | -67 | -20 | N/A |
3/31/2019 | 57 | -12 | -53 | -16 | N/A |
12/31/2018 | 41 | -2 | -40 | -10 | N/A |
9/30/2018 | 28 | 0 | -26 | -4 | N/A |
6/30/2018 | 19 | 1 | -23 | -7 | N/A |
3/31/2018 | 13 | 1 | -14 | -6 | N/A |
12/31/2017 | 10 | -3 | -10 | -5 | N/A |
12/31/2016 | 3 | -8 | N/A | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: CL is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CL is expected to become profitable in the next 3 years.
Revenue vs Market: CL's revenue (5.1% per year) is forecast to grow slower than the Canadian market (6.7% per year).
High Growth Revenue: CL's revenue (5.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CL's Return on Equity is forecast to be high in 3 years time